Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 53Neoplasms 44Prostatic Neoplasms 43Breast Neoplasms 38Neoplasm Metastasis 21Unspecified Adult Solid Tumor, Protocol Specific 19Lung Neoplasms 18Head and Neck Neoplasms 17Squamous Cell Carcinoma of Head and Neck 16Ovarian Neoplasms 15Advanced Solid Tumors 11Stomach Neoplasms 9Sarcoma 9Pancreatic Neoplasms 9Solid Tumor 8Melanoma 8Esophageal Neoplasms 8Carcinoma, Ovarian Epithelial 8Urinary Bladder Neoplasms 7Fallopian Tube Neoplasms 7Colorectal Neoplasms 7Small Cell Lung Carcinoma 6Salivary Gland Neoplasms 6Esthesioneuroblastoma, Olfactory 5Esophageal Squamous Cell Carcinoma 5Carcinoma, Renal Cell 5Breast Neoplasms, Male 5Triple Negative Breast Neoplasms 4Recurrence 4Endometrial Neoplasms 4

Interventions

aldesleukin 2Trastuzumab 2Pharmaceutical Preparations 2Interleukin-2 2Carboplatin 2Bevacizumab 2tocilizumab 1tipifarnib 1romidepsin 1lipoplatin 1Verteporfin 1Valacyclovir 1Tyrosine Kinase Inhibitors 1Sorafenib 1SPI-77, liposomal 1Povidone-Iodine 1Pleurodesis 1Photochemotherapy 1Paclitaxel 1LMB-100 1Interleukin-12 Subunit p35 1Interleukin-12 1Immunotherapy, Adoptive 1Gemcitabine 1Erlotinib Hydrochloride 1Docetaxel 1Decitabine 1Dasatinib 1Cytoreduction Surgical Procedures 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Pleural Effusion, Malignant × Docetaxel × Clear all
NCT00114205 2010-03-18

Surgery and Intrapleural Docetaxel in Treating Patients With Malignant Pleural Effusion

National Cancer Institute (NCI)

Phase 1 Completed
24 enrolled
Thoracic

Neoplasm Metastasis, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡